AzTrials
AzTrials

SpeechBRAVA²NCT04547569

Somesthesic Role of the Ventro-lateral Prefrontal Cortex in Speech Motor Learning

A study testing Speech adaptation, Vibrotactile Discrimination and fMRI in people with Speech and Motor Activity, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

These studies test the hypothesis that frontal areas of the brain participate in the cortical networks involved in the somotosensory processing that happens during speech motor learning. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Speech, Motor Activity
What is being tested?
Speech adaptation, Vibrotactile Discrimination and fMRI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteFrance
Study dates
20 Oct 2020to 6 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Right-handed subjects
  • Subjects fluent in French
  • Signed informed consent
  • Affiliation to or beneficiary of a Social Security scheme

Who cannot join

  • Left-handed subjects
  • Criteria for contraindications to protocol fMRI scans
  • Existence of a severe general condition: cardiac, respiratory, hematological, renal, hepatic, cancerous.
  • Hearing, language (including dyslexia), neurological or psychiatric disorders.
  • Participation in other ongoing intervention research protocols with exclusionary period or within the previous week
  • Drug treatment likely to modulate brain activity: benzodiazepines, antidepressants, neuroleptics, lithium, etc.
Show all 13Show fewer
  • Protected persons referred to in articles L1121 5 to L1121 8 of the French CSP:
  • Pregnant women, parturients, nursing mothers,
  • Persons deprived of liberty by a judicial or administrative decision,
  • Persons under psychiatric care,
  • Individuals admitted to a health or social institution for purposes other than research,
  • Minors,
  • Persons over the age of majority who are subject to a legal protection measure or who are unable to express their consent

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Grenoble-Alpes

    Grenoble, 38043

Other trials in France

About this study

Official title: Somesthesic Role of the Ventro-lateral Prefrontal Cortex in Speech Motor Learning fMRI Study

These studies test the hypothesis that frontal areas of the brain participate in the cortical networks involved in the somotosensory processing that happens during speech motor learning.

Read the detailed description

This work aims to study the role of sensory systems in human motor learning and specifically addresses the involvement of somatosensory cortical networks in motor learning of speech. Previous studies in the literature have highlighted the plasticity of cortical sensory networks, notably the primary and secondary somatosensory cortex and the ventral premotor cortex, during motor learning tasks. The present project focuses on the somatosensory region with connections to the sensorimotor regions of the frontal and parietal cortex. We propose to use neuroimaging (fMRI), in order to verify which areas in the prefrontal cortex are part of the sensorimotor network used in the learning of speech motor tasks in humans. Subjects will be tested in the fMRI scanner while performing either a behavioral task in which the auditory feedback of their own speech is altered or while performing a vibrotactile discrimination task.

Being tested
Speech adaptation, Vibrotactile Discrimination, fMRI, Speech production
Medical subject headings
Speech, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Speech adaptationBehavioural

    Sensorimotor adaptation in speech

  • Vibrotactile DiscriminationBehavioural

    Vibrotactile Discrimination

  • fMRIOther

    fMRI measurement of brain activity

  • Speech productionBehavioural

    Speech production task

Study groups in NCT04547569
Study groupRoleWhat they receive
Adaptation to altered auditory feedbackExperimentalfMRI measurement of brain activity during speech production under altered auditory feedback
Receives: Behavioral: Speech adaptation; Other: fMRI
Speech productionExperimentalfMRI measurement of brain activity during normal speech production
Receives: Other: fMRI; Behavioral: Speech production
Vibrotactile discriminationExperimentalfMRI measurement of brain activity during a vibrotactile discrimination task
Receives: Behavioral: Vibrotactile Discrimination; Other: fMRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor Learning

    Learning is assessed as percentage change in speech sounds (speech formant frequencies) relative to baseline.

    Measured: Performance as measured at the end of learning (during the 1h30 scanner session)

  2. Brain activity

    Brain activity are measure by the BOLD signal during both task-based and resting-state blocks

    Measured: 1h30 scanner session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2020
  2. Study start20 Oct 2020
  3. Primary completion6 Jul 2021
  4. Study completion6 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04547569
Sponsor's protocol ID
38RC18.173
Acronym
BRAVA²
Status last verified
May 2022
First submitted
7 Sep 2020
Last updated
1 Jun 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Speech adaptation, Vibrotactile Discrimination and fMRI in people with Speech and Motor Activity, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor Learning (time frame: Performance as measured at the end of learning (during the 1h30 scanner session)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in